This is in agreement with Karjalainen et al 201117 who examined Neuropilin-1 in patients with acute leukemia and demonstrated its expression, above baseline bone marrow levels, in all B-cell ALL samples and in two thirds of AML samples with stronger expression in blast cells of B-cell ALL than AML blast cells.17 Similarly, Meyerson et al 201222 found that Neuropilin-1 is frequently expressed on B-ALL blasts (71%), whereas its expression is less frequent on AML blasts (22.9%) and consistently absent on peripheral blood lymphocytes.22 Here, NRP1 is linked to acute myeloid leukemia.